Division for Organizational Health Services Research, School of Medicine and Health Sciences, Carl von Ossietzky University of Oldenburg, Ammerlaender Heerstr, 140, 26129 Oldenburg, Germany.
Division for Assistance Systems and Medical Technology, School of Medicine and Health Sciences, Carl von Ossietzky University of Oldenburg, Ammerlaender Heerstr, 140, 26129 Oldenburg, Germany.
Int J Environ Res Public Health. 2022 Jul 28;19(15):9265. doi: 10.3390/ijerph19159265.
The development of immunotherapy in the treatment for lung cancer has changed the outlook for both patients and health care practitioners. However, reporting and management of side effects are crucial to ensure effectiveness and safety of treatment. The aim of this study was to learn about the subjective experiences of patients with lung cancer receiving immunotherapy and to explore their potential acceptance of digital and sensor-based systems for monitoring treatment-related symptoms at home.
A qualitative-explorative interview study with patients with lung cancer ( = 21) applying qualitative content analysis.
Participants had trouble to classify and differentiate between symptoms they experienced and it seemed challenging to assess whether symptoms are serious enough to be reported and to figure out the right time to report symptoms to health care practitioners. We identified four basic needs: (1) the need to be informed, (2) the need for a trustful relationship, (3) the need to be taken seriously, and (4) the need for needs-oriented treatment concepts. The idea of digital and sensor-based monitoring initially provoked rejection, but participants expressed more differentiated attitudes during the interviews, which could be integrated into a preliminary model to explain the acceptance of digital and sensor-based monitoring scenarios.
Supporting lung cancer patients and their health care providers in communicating about treatment-related symptoms is important. Technology-based monitoring systems are considered to be potentially beneficial. However, in view of the many unfulfilled information needs and the unsatisfactory reporting of symptoms, it must be critically questioned what these systems can and should compensate for, and where the limits of such monitoring lie.
免疫疗法在肺癌治疗中的发展改变了患者和医疗保健从业者的前景。然而，报告和管理副作用对于确保治疗的有效性和安全性至关重要。本研究旨在了解接受免疫疗法的肺癌患者的主观体验，并探讨他们对在家中监测与治疗相关症状的数字和基于传感器的系统的潜在接受程度。
采用定性探索性访谈研究，对 21 名肺癌患者（ = 21）进行定性内容分析。
参与者难以对他们所经历的症状进行分类和区分，并且评估症状是否严重到足以报告以及确定向医疗保健从业者报告症状的正确时间似乎具有挑战性。我们确定了四个基本需求：（1）需要知情，（2）需要建立信任关系，（3）需要得到重视，以及（4）需要以需求为导向的治疗概念。数字和基于传感器的监测的想法最初引起了拒绝，但参与者在访谈中表达了更为不同的态度，可以将这些态度整合到一个初步模型中，以解释对数字和基于传感器的监测场景的接受程度。
支持肺癌患者及其医疗保健提供者就与治疗相关的症状进行沟通很重要。基于技术的监测系统被认为具有潜在的益处。然而，鉴于许多未满足的信息需求和症状报告的不理想情况，必须批判性地询问这些系统可以和应该弥补什么，以及这种监测的局限性在哪里。
